Accelerating glioblastoma therapeutics via venture philanthropy

Accelerating glioblastoma therapeutics via venture philanthropy

Development of curative treatments for glioblastoma (GBM) has been stagnant in recent decades largely because of significant financial risks. A portfolio-based strategy for the parallel discovery of breakthrough therapies can effectively reduce the financial risks of potentially transformative clini...

Full description

Bibliographic Details
Main Authors: Siah, Kien Wei, Xu, Qingyang, Tanner, Kirk, Futer, Olga, Frishkopf, John J, Lo, Andrew W
Other Authors: Sloan School of Management. Laboratory for Financial Engineering
Format: Article
Language:English
Published: Elsevier BV 2022
Online Access:https://hdl.handle.net/1721.1/144204

Internet

https://hdl.handle.net/1721.1/144204

Similar Items